# Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order

> **NCT00282165** · PHASE4 · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 8 (actual)

## Conditions studied

- Psychotic Disorders
- Antisocial Personality Disorder
- Impulse Regulation Disorder
- Intermittent Explosive Disorder

## Interventions

- **DRUG:** naratriptan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00282165
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Required number of subjects to be included could not be accomplished
- **Last updated:** 2015-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282165, "Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00282165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*